| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
|---|---|---|---|---|---|---|
| CP008583 |
|
16807-11-7 |
1-Bromo-9H-carbazole - 98% |
0 | C12H8BrN | |
| CP008582 |
|
120-18-3 |
Naphthalene-2-sulfonic acid - 98% |
0 | C10H8O3S | |
| CP008581 |
|
100124-06-9 |
DIBENZOFURAN-4-BORONIC ACID - 98% |
0 | C12H9BO3 | |
| CP008580 |
|
625095-57-0 |
(S)-1-(3-Chlorophenyl)-1,3-propanediol - 98% |
0 | C9H11ClO2 | |
| CP008579 |
|
943516-54-9 |
6,6-DiMethyl-3-azabicyclo[3.1.0]hexane Boceprevir Key interMediate - 98% |
0 | C7H13N | |
| CP008578 |
|
94-62-2 |
Piperine - 95%-102% |
0 | C17H19NO3 | |
| CP008577 |
|
102691-36-1 |
2-Cyanoethyl N,N,N',N'-tetraisopropylphosphorodiamidite - 95%-102% |
0 | C15H32N3OP | |
| CP008575 |
|
155206-00-1 |
Bimatoprost - 98% |
0 | C25H37NO4 | |
| CP008574 |
|
67914-69-6 |
ELUBIOL - 98% |
0 | C27H30Cl2N4O5 | |
| CP008573 |
|
174722-31-7 |
Rituximab - 98% |
0 | — | |
| CP008572 |
|
170277-31-3 |
Infliximab - 98% |
0 | — | |
| CP008571 |
|
911417-23-7 |
4(3H)-Quinazolinone, 2-(3-hydroxyphenyl)- - 98% |
0 | C14H10N2O2 | |
| CP008570 |
|
15356-60-2 |
(+)-MENTHOL - 98% |
0 | C10 H20 O | |
| CP008568 |
|
306-08-1 |
Homovanillic acid - 98% |
0 | C9H10O4 | |
| CP008567 |
|
618-27-9 |
cis-4-Hydroxy-L-proline - 98% |
0 | C5H9NO3 | |
| CP008566 |
|
1380723-44-3 |
Atezolizumab - 98% |
0 | — | |
| CP008565 |
|
110-15-6 |
Succinic acid - 99% |
0 | C4H6O4 | |
| CP008564 |
|
870487-09-5 |
Boc-Val-Cit-PABA - 98% |
0 | C23H37N5O6 | |
| CP008563 |
|
— |
N/A - 75% 蛋白质含量 |
0 | — | |
| CP008562 |
|
— |
N/A - 98% |
0 | — | |
